#DAFNA Capital

DAFNA Capital Adjusts iShares Biotechnology ETF Holdings in Strategic Portfolio Shift

DAFNA Capital's recent SEC filing indicates a recalibration of its iShares Biotechnology ETF holdings, reflecting a broader strategic adjustment in its biotech investments.